PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
NCT05033392
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
62
Enrollment
OTHER
Sponsor class
Conditions
Stomach Neoplasms
Interventions
DRUG:
Toripalimab Injection
Sponsor
Wan He